Tarbell N J, Loeffler J S
Joint Center for Radiation Therapy, Children's Hospital, Harvard Medical School, Boston MA, USA.
J Neurooncol. 1996 May-Jun;28(2-3):233-44. doi: 10.1007/BF00250202.
The management of pediatric gliomas is controversial, and is greatly influenced by the site of origin of the tumor. For example, cerebellar low grade tumors are often cured by surgery alone. This is in contrast to the hypothalamic and optic system tumors which are usually not amenable to complete resection. For the low grade astrocytomas, the usual indications for adjuvant treatment include: recurrent tumors after initial complete resection or symptomatic tumors that have been incompletely excised. In addition, treatment is generally indicated in tumors with growth on follow-up imaging, even in the absence of symptoms. In selecting the optimal treatment, the relative efficacies of surgery, chemotherapy and irradiation must be balanced by the potential complications of therapy. The potential risks of delayed intervention include irreversible neurologic impairment and potential lower probability of tumor control. This chapter reviews recent trends in the radiotherapeutic management of pediatric low-grade and malignant astrocytomas, particularly the new more conformal techniques that hold the promise of reduced toxicity in children requiring irradiation.
小儿胶质瘤的治疗存在争议,且受肿瘤起源部位的影响很大。例如,小脑低度肿瘤通常仅通过手术就能治愈。这与下丘脑和视神经系统肿瘤形成对比,后者通常无法进行完全切除。对于低度星形细胞瘤,辅助治疗的常见指征包括:初次完全切除后复发的肿瘤或未完全切除的有症状肿瘤。此外,即使没有症状,随访影像学检查显示肿瘤生长的情况下通常也需要进行治疗。在选择最佳治疗方案时,手术、化疗和放疗的相对疗效必须与治疗的潜在并发症相平衡。延迟干预的潜在风险包括不可逆转的神经功能损害以及肿瘤控制概率可能降低。本章回顾了小儿低度和恶性星形细胞瘤放射治疗管理的最新趋势,特别是那些有望降低需要放疗的儿童毒性的新型更适形技术。